Research from Pittsburgh explores the potential of next-generation mRNA vaccines to be more cost-effective and efficient. Despite initial funding for mRNA vaccine development during the COVID-19 pandemic, recent skepticism from government officials has raised concerns about the technology’s safety and efficacy. President Donald Trump’s administration canceled a significant contract for an mRNA flu vaccine, citing […]